Brief: Radius Health Update On Abaloparatide Transdermal System

Radius Recycling

01/06/2022 22:21

June 1 (Reuters) - Radius Health Inc  RDUS.O :
    * RADIUS HEALTH UPDATE ON ABALOPARATIDE TRANSDERMAL SYSTEM
    * RADIUS HEALTH INC - ASCERTAINED REGULATORY CLARITY FOR
POSSIBLE
FORWARD PROGRESSION OF ABALO-TDS
    * RADIUS HEALTH INC - ADDITIONAL AND SUCCESSFUL CLINICAL
TRIAL
WOULD BE REQUIRED TO ADVANCE TOWARDS AN NDA FILING FOR ABALO-TDS
    * RADIUS HEALTH INC - BASED ON REGULATORY CLARITY, TIMELINE,
AND
COSTS, RADIUS WILL CEASE ALL WORK ON ABALO-TDS PROGRAM

Source text for Eikon:  ID:nGNX54259J 
Further company coverage:  RDUS.O